Gene Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Cell and Gene Therapy Market and Competitive Analysis. The Market is Segmented by Indication (Cancer, Metabolic Disorders, Eye Disorders, Spinal Muscular Atrophy, and Other Indications), Technology (Adeno Virus Vector, Adeno-associated Virus Vector, Lentiviral Vector, Retroviral Vector, Herpes Virus Vector, and Other Technologies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Gene Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Gene Therapy Industry Overview

The gene therapy market is highly competitive and consists of several significant players. Companies like Amgen Inc., Bluebird Bio, Gilead Sciences, Inc., Novartis AG, Orchard Therapeutics, Sibiono GeneTech Co. Ltd, Spark Therapeutics (Roche AG), and UniQure NV hold a substantial market share. They have various strategic alliances, such as collaborations and acquisitions, along with the launch of advanced products to secure their position in the global market.

Gene Therapy Market Leaders

  1. Gilead Sciences, Inc.

  2. Novartis

  3. Amgen Inc.

  4. Bluebird Bio

  5. Biogen Inc

  6. *Disclaimer: Major Players sorted in no particular order
Gene Therapy Market Concentration